The Lanxess specialized chemical company has completed the sale of its Uretano systems business to the Japanese UBE Corporation on April 1, 2025. UBE is a global manufacturer of chemicals and in the Tokyo Stock Exchange.
All relevant antitrust authorities had granted the necessary approvals for the transaction, which was announced in October 2024. With the completion of this transaction, LANXESS has received gross revenues in cash of approximately € 500 million. The business value amounts to € 460 million.
Lanxess intends to use income to exchange its reference bonus of 500 million euros that matures in May 2025. The leverage rate (net financial debt / Ebitda pre) will be reduced to ~ 3x.
“With this sale, we conclude the transformation of our portfolio and, at the same time, we achieved a substantial reduction of net financial debt,” he says Matthias Zachert, president of the LANXESS AG Management Board.
For more information, visit https://lanxess.com/.
